Proxy Votes Now

Home › Funds › Equitable › EQ/MFS International Intrinsic Value Portfolio

EQ/MFS International Intrinsic Value Portfolio proxy voting record 2025-2026

Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000062641

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,402 with, 18 against, 2 abstentions (not counted as with management); 10 items carried no recommendation. Shareholder proposals: 7 FOR, 13 AGAINST, 4 abstained, by the filing’s own vote-source field.

Compared with Equitable as a whole

The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEquitableItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)98.1%1,19892.5%339,726
Backed environmental and social shareholder proposals at US companiesn/a09.6%3,486

Where this fund voted differently from most Equitable funds

Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Equitable funds on 24 items (2.0% of the 1,185 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Smith & Nephew plc2026-05-06Approve Performance Share PlanForAGAINST — 9 of 9 Equitable fundsFor—
Smith & Nephew plc2026-05-06Approve Remuneration PolicyForAGAINST — 9 of 9 Equitable fundsFor—
Shimano, Inc.2026-03-24Shareholder Initiate Share Repurchase ProgramForAGAINST — 9 of 9 Equitable fundsAgainst—
Shimano, Inc.2026-03-24Elect Director Shimano, YozoAgainstFOR — 9 of 9 Equitable fundsAgainst—
Aker BP ASA2026-04-21Approve Creation of Up to NOK 31.6 Million Pool of Capital without Preemptive RightsForAGAINST — 8 of 8 Equitable fundsFor—
Knorr-Bremse AG2026-04-30Approve Remuneration ReportForAGAINST — 7 of 7 Equitable fundsFor—
Knorr-Bremse AG2026-04-30Elect Reinhard Ploss to the Supervisory BoardForAGAINST — 7 of 7 Equitable fundsFor—
Novonesis (Novozymes A/S)2026-03-23Reelect Heine Dalsgaard (Vice Chair) as DirectorAbstainFOR — 7 of 7 Equitable fundsAgainst—
Novonesis (Novozymes A/S)2026-03-23Reelect Kasim Kutay Lane as DirectorAbstainFOR — 7 of 7 Equitable fundsAgainst—
Resona Holdings, Inc.2026-06-24Elect Director Minami, MasahiroAgainstFOR — 9 of 10 Equitable fundsAgainst—
Schneider Electric SE2026-05-07Reelect Anders Runevad as DirectorForAGAINST — 8 of 9 Equitable fundsFor—
Svenska Cellulosa AB SCA2026-03-27Reelect Asa Bergman as DirectorForAGAINST — 8 of 9 Equitable fundsFor—
Svenska Cellulosa AB SCA2026-03-27Reelect Martin Lindqvist as DirectorForAGAINST — 8 of 9 Equitable fundsFor—
Compagnie Financiere Richemont SA2025-09-10Approve Variable Remuneration of Executive Committee in the Amount of CHF 30.6 MillionForAGAINST — 7 of 8 Equitable fundsFor—
Compagnie Financiere Richemont SA2025-09-10Reappoint Fiona Druckenmiller as Member of the Compensation CommitteeForAGAINST — 7 of 8 Equitable fundsFor—
Compagnie Financiere Richemont SA2025-09-10Reappoint Jasmine Whitbread as Member of the Compensation CommitteeForAGAINST — 7 of 8 Equitable fundsFor—
Compagnie Financiere Richemont SA2025-09-10Reappoint Keyu Jin as Member of the Compensation CommitteeForAGAINST — 7 of 8 Equitable fundsFor—
Dassault Systemes SE2026-05-20Approve Compensation of Bernard Charles, Chairman of the BoardForAGAINST — 7 of 9 Equitable fundsFor—
Tenaris SA2026-05-12Elect Directors (Bundled)ForAGAINST — 4 of 5 Equitable fundsFor—
EssilorLuxottica SA2026-04-28Approve Compensation Report of Corporate OfficersForAGAINST — 5 of 9 Equitable fundsFor—
EssilorLuxottica SA2026-04-28Approve Compensation of Francesco Milleri, Chairman and CEOForAGAINST — 5 of 9 Equitable fundsFor—
EssilorLuxottica SA2026-04-28Approve Compensation of Paul du Saillant, Vice-CEOForAGAINST — 5 of 9 Equitable fundsFor—
Aker BP ASA2026-04-21Reelect Charles Ashley Heppenstall as DirectorForAGAINST — 4 of 7 Equitable fundsFor—
Aker BP ASA2026-04-21Reelect Doris Reiter as DirectorForAGAINST — 4 of 7 Equitable fundsFor—

Download all 24 differences (CSV)

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections6673
Capital Structure2475
Corporate Governance2038
Compensation1962
Audit-related820
Extraordinary Transactions170
Other Social Issues90
Say-on-Pay50
Other30
Environment or Climate20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Taiwan Semiconductor Manufacturing Co., Ltd.June 4, 2026$50M30
Agilent Technologies, Inc.March 18, 2026$24M70
Waters CorporationMay 21, 2026$18M130
Waters CorporationJanuary 27, 2026$17M20
NICE Ltd. (Israel)September 30, 2025$3M120

Notable votes against management

MeetingCompanyProposalFundMgmt
June 25, 2026Toyo Suisan Kaisha, Ltd.Initiate Share Repurchase Program Shareholder proposalAgainstFor
June 25, 2026Toyo Suisan Kaisha, Ltd.Approve Restricted Stock Plan Shareholder proposalAgainstFor
March 24, 2026Shimano, Inc.Initiate Share Repurchase Program Shareholder proposalForAgainst
March 23, 2026Novonesis (Novozymes A/S)Account for Ethical Policies and Ensure Compliance Frameworks in Practice Shareholder proposalAgainstFor
June 24, 2026Rohto Pharmaceutical Co., Ltd.Remove Incumbent Director Yamada, Kunio Shareholder proposalAgainstFor
June 24, 2026Rohto Pharmaceutical Co., Ltd.Amend Articles to Establish Strategic Review Committee Shareholder proposalAgainstFor
March 24, 2026Ezaki Glico Co., Ltd.Appoint Shareholder Director Nominee James B. Rosenwald III Shareholder proposalForAgainst
March 24, 2026Ezaki Glico Co., Ltd.Appoint Shareholder Director Nominee Sano, Junichiro Shareholder proposalForAgainst

Search this fund’s votes by company

1,432 ballot items at 89 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, EQ/MFS International Intrinsic Value Portfolio voted at 89 shareholder meetings of 84 companies, on 1,432 ballot items in all. Where management made a recommendation, the fund followed it on 98.6% of the items and voted against it 18 times. Its most frequent area of disagreement was corporate governance (8 of its votes against management). It voted on 24 shareholder proposals. It voted FOR the board's own proposals more often than Equitable's funds as a whole (98.1% against 92.5%). It voted differently from most Equitable funds on 24 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.